RTOG Initiates a Phase I Trial Testing the Therapy Ganitumab for Locally Advanced Pancreatic Cancer
Wednesday, December 14, 2011 - 17:00
in Health & Medicine
Conducted by the Radiation Therapy Oncology Group (RTOG), the results of the RTOG 1102 are expected to provide important dosing and safety information needed prior to advancing ganitumab evaluation to a phase II randomized trial.